Unknown

Dataset Information

0

XMRV and prostate cancer--a 'final' perspective.


ABSTRACT: XMRV was first described in 2006, when it was identified in samples isolated from prostate cancer tissues. However, studies have since shown that XMRV arose in the laboratory and was formed by genetic recombination between two viral genomes carried in the germline DNA of mice used during serial transplantation of the CWR22 prostate cancer xenograft. These new findings strongly imply that XMRV does not circulate in humans, but is only present in the laboratory. Thus, there is no reason to believe that it has any role in the etiology of prostate cancer or other diseases.

SUBMITTER: Sfanos KS 

PROVIDER: S-EPMC4029112 | biostudies-literature | 2012 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

XMRV and prostate cancer--a 'final' perspective.

Sfanos Karen S KS   Aloia Amanda L AL   De Marzo Angelo M AM   Rein Alan A  

Nature reviews. Urology 20120110 2


XMRV was first described in 2006, when it was identified in samples isolated from prostate cancer tissues. However, studies have since shown that XMRV arose in the laboratory and was formed by genetic recombination between two viral genomes carried in the germline DNA of mice used during serial transplantation of the CWR22 prostate cancer xenograft. These new findings strongly imply that XMRV does not circulate in humans, but is only present in the laboratory. Thus, there is no reason to believe  ...[more]

Similar Datasets

| S-EPMC3005136 | biostudies-literature
| S-EPMC3353988 | biostudies-literature
| S-EPMC3077333 | biostudies-literature
| PRJEB2372 | ENA
| S-EPMC3275676 | biostudies-literature
| S-EPMC2770519 | biostudies-literature
| S-EPMC4963806 | biostudies-literature
| S-EPMC10424402 | biostudies-literature
| S-EPMC3192048 | biostudies-literature
| S-EPMC2848589 | biostudies-literature